Studies have shown that testes-specific protease 50 (TSP50) can maintain a low level of PKM2 tetramers by acetylating the K433 site of PKM2, thereby inhibiting its activity and promoting aerobic glycolysis and tumor progression in HCC (51). This evidence concerns the gene PRSS50 and hepatocellular carcinoma.